Lannett Co. Inc. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
57,101.00
149,992.00
44,857.00
547.00
28,690.00
Depreciation, Depletion & Amortization
5,984.00
5,583.00
33,433.00
55,340.00
55,115.00
Other Funds
7,017.00
8,036.00
1,487.00
36,500.00
-
Funds from Operations
70,716.00
150,027.00
92,967.00
170,133.00
184,271.00
Changes in Working Capital
25,613.00
21,509.00
42,310.00
4,760.00
65,748.00
Net Operating Cash Flow
45,103.00
128,518.00
135,277.00
165,373.00
118,523.00
Capital Expenditures
26,082.00
31,976.00
24,267.00
48,694.00
71,354.00
Sale of Fixed Assets & Businesses
48.00
94.00
16.00
112.00
28.00
Purchase/Sale of Investments
30,325.00
27,931.00
638.00
10,083.00
30,404.00
Net Investing Cash Flow
56,359.00
45,813.00
959,067.00
58,665.00
51,176.00
Issuance/Reduction of Debt, Net
5,778.00
564.00
843,867.00
178,233.00
85,705.00
Net Financing Cash Flow
74,161.00
12,289.00
848,219.00
213,813.00
86,205.00
Net Change in Cash
62,898.00
94,753.00
24,429.00
107,032.00
19,151.00
Free Cash Flow
19,021.00
96,842.00
111,010.00
116,679.00
66,207.00
Deferred Taxes & Investment Tax Credit
12,886.00
3,266.00
19,497.00
305.00
30,690.00
Net Assets from Acquisitions
-
41,862.00
934,178.00
-
-
Change in Capital Stock
72,922.00
4,817.00
2,865.00
920.00
500.00
Exchange Rate Effect
7.00
241.00
-
73.00
293.00
Other Uses
-
-
-
-
10,254.00

About Lannett Co.

View Profile
Address
9000 State Road
Philadelphia Pennsylvania 19136
United States
Employees -
Website http://www.lannett.com
Updated 07/08/2019
Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escltalopram oxalate; renitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA.